Literature DB >> 21844575

Identification and characterization of OXA-48 producing, carbapenem-resistant Enterobacteriaceae isolates in Turkey.

Abdullah Kilic1, Zerin Aktas, Orhan Bedir, Ramazan Gumral, Yasemin Bulut, Charles Stratton, Yi-Wei Tang, A Celal Basustaoglu.   

Abstract

Carbapenem resistance in Enterobacteriaceae isolates has been reported from Turkey and is most often mediated by OXA-48 type carbapenemases. We report the identification and characterization of four carbapenem-resistant isolates (three Klebsiella pneumoniae and one Escherichia coli) among 515 clinical Enterobacteriaceae isolates collected during a 7-month study period in Ankara, Turkey. The four isolates were recovered from blood and urine specimens in patients with varied clinical manifestations. They had distinct pulsed-field gel electrophoresis patterns and harbored a variety of β-lactamases including bla(TEM-1), bla(SHV-12) genes, bla(SHV-11), and/or bla(CTX-M-15). PCR and sequencing analysis revealed that the bla(OXA-48) gene was present in all four isolates. Our data indicated that the OXA-48-type carbapenemase was the only mechanism for carbapenem resistance in our hospital.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21844575

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  8 in total

1.  First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria.

Authors:  A Agabou; A Pantel; Z Ouchenane; N Lezzar; S Khemissi; D Satta; A Sotto; J-P Lavigne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-05       Impact factor: 3.267

2.  Class D β-lactamases: are they all carbapenemases?

Authors:  Nuno T Antunes; Toni L Lamoureaux; Marta Toth; Nichole K Stewart; Hilary Frase; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

Review 3.  OXA-48-like carbapenemases producing Enterobacteriaceae in different niches.

Authors:  Assia Mairi; Alix Pantel; Albert Sotto; Jean-Philippe Lavigne; Aziz Touati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-08       Impact factor: 3.267

4.  The First Klebsiella pneumoniae Isolate Co-Producing OXA-48 and NDM-1 in Turkey.

Authors:  Abdullah Kilic; Mehmet Baysallar
Journal:  Ann Lab Med       Date:  2015-04-01       Impact factor: 3.464

Review 5.  Dissemination of carbapenemases producing Gram negative bacteria in the Middle East.

Authors:  Abed Zahedi Bialvaei; Hossein Samadi Kafil; Hamed Ebrahimzadeh Leylabadlo; Mohammad Asgharzadeh; Mohammad Aghazadeh
Journal:  Iran J Microbiol       Date:  2015-10

6.  Osteomyelitis due to multiple carbapenemase-producing Gram-negative bacteria: The first case report of a GES-13-producing Pseudomonas aeruginosa isolate in Canada.

Authors:  Shadi Sepehri; Guillaume Poliquin; Nora Alfattoh; David Boyd; Michael Mulvey; Andrew Denisuik; Sergio Fanella; James Karlowsky; Andrew Walkty
Journal:  Can J Infect Dis Med Microbiol       Date:  2014-07       Impact factor: 2.471

Review 7.  Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae.

Authors:  Hayley Wilson; M Estée Török
Journal:  Microb Genom       Date:  2018-07-23

Review 8.  Understanding the Epidemiology of Multi-Drug Resistant Gram-Negative Bacilli in the Middle East Using a One Health Approach.

Authors:  Iman Dandachi; Amer Chaddad; Jason Hanna; Jessika Matta; Ziad Daoud
Journal:  Front Microbiol       Date:  2019-08-23       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.